Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Ra Medical Systems, Inc. (RMED)

NYSE American - NYSE American Delayed Price. Currency in USD
Add to watchlist
0.3090-0.0051 (-1.62%)
At close: 04:00PM EDT
0.3057 -0.00 (-1.07%)
After hours: 07:37PM EDT
Advertisement
Full screen
Loading interactive chart...
  • Business Wire

    Ra Medical Systems Reports First Quarter 2022 Financial Results

    CARLSBAD, Calif., May 16, 2022--Ra Medical Systems, Inc. (NYSE American: RMED) ("Ra Medical" or "the Company"), a medical device company focusing on developing its excimer laser system to treat vascular disease, reports financial results for the three months ended March 31, 2022 and provides a business update.

  • Business Wire

    Ra Medical Systems to Report First Quarter 2022 Financial Results on May 16, 2022

    CARLSBAD, Calif., May 09, 2022--Ra Medical Systems, Inc. (NYSE American: RMED) announces that it will report financial results for the three months ended March 31, 2022 after market close on Monday, May 16. Ra Medical management will hold an investment community conference call that day at 1:30 p.m. Pacific time (4:30 p.m. Eastern time) to discuss financial results and provide a company update.

  • Business Wire

    Ra Medical Systems Granted U.S. Patent for Laser Ablation Catheters with Expanded Ablation Area

    CARLSBAD, Calif., April 05, 2022--Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focusing on developing its excimer laser system to treat vascular diseases, announces the United States Patent and Trademark Office has granted the company a patent for liquid-filled laser ablation catheters with expanded distal optical windows. U.S. patent 11,284,941 (the ’941 patent), titled Laser Ablation Catheters Having Expanded Distal Tip Windows for Efficient Tissue Ablation, describ

Advertisement
Advertisement